US Broker Ratings

Legend Biotech Corporation (LEGN): Investor Outlook on a Potential 101% Upside in the Biotechnology Sector

Legend Biotech Corporation (NASDAQ: LEGN) is making waves in the biotechnology sector with its promising cell therapy innovations. Headquartered in Somerset, New Jersey, Legend Biotech is a key player in..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Potential 21.52% Upside Sparks Investor Interest

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising growth potential. Specializing in innovative treatments for B-cell mediated..

BioNTech SE (BNTX) Stock Analysis: 40% Potential Upside Beckons Investors

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has been a focal point for investors ever since its groundbreaking contribution to the COVID-19 pandemic with the development..

Bruker Corporation (BRKR) Stock Analysis: A 14.63% Upside Potential in the Innovative Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR) stands as a prominent player in the healthcare sector, specializing in the medical devices industry. With a market capitalization of $6.53 billion, Bruker is known for..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating Potential in Healthcare’s Frontier with a $14.13 Billion Market Cap

Regencell Bioscience Holdings Limited (RGC), a prominent player in the healthcare sector, is making waves with its innovative approach to Traditional Chinese Medicine (TCM) for neurocognitive disorders. With a market..

Glaukos Corporation (GKOS) Stock Analysis: Strong Buy Ratings Signal Promising Upside in the Medical Device Arena

Glaukos Corporation (NYSE: GKOS), a pioneering force in the healthcare sector, particularly within the medical devices industry, is catching the attention of investors with its innovative approach to ophthalmic treatments...

DaVita Inc. (DVA) Investor Outlook: Navigating Growth with Robust Returns and Strategic Positioning

DaVita Inc. (NYSE: DVA), a leader in the healthcare sector, specifically within the medical care facilities industry, commands significant attention from investors due to its specialized focus on providing kidney..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring the 12% Upside Potential in Eye Health

Investors with an eye on the healthcare sector may find Bausch + Lomb Corporation (NYSE: BLCO) an intriguing opportunity. With a market capitalization of $5.74 billion, this Canadian company has..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: A Potential 89% Upside in Innovative RNA Therapies

Atrium Therapeutics, Inc. (RNA) is making waves in the biotechnology sector with its pioneering work in RNA therapeutics aimed at transforming care for people with cardiomyopathies. Despite its relatively recent..

Sanofi (SNY) Stock Analysis: Evaluating a 30.94% Upside Potential for Healthcare Investors

Sanofi (NASDAQ: SNY), a global healthcare leader based in Paris, France, presents a compelling investment opportunity for those interested in the drug manufacturing industry. With a substantial market capitalization of..

Exelixis, Inc. (EXEL) Stock Analysis: Evaluating Growth Prospects Amidst Analyst Divergence

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, is making waves with its innovative oncology treatments. Based in Alameda, California, this company has been at the forefront..

Revvity, Inc. (RVTY): Investor Outlook Reveals 20.94% Potential Upside in Healthcare Innovation

Revvity, Inc. (NASDAQ: RVTY), a significant player in the healthcare sector, is drawing attention from investors seeking growth in the diagnostics and research industry. With a robust market capitalization of..

Cencora, Inc. (COR) Stock Analysis: Exploring a 38.53% Potential Upside with Strong Buy Ratings

Cencora, Inc. (NYSE: COR), a prominent player in the healthcare sector, stands out in the medical distribution industry with its substantial market capitalization of $50.14 billion. As it undergoes a..

Option Care Health, Inc. (OPCH) Stock Analysis: Uncovering a 49.50% Potential Upside in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Bannockburn, Illinois, the company is a..

Fresenius Medical Care AG (FMS) Stock Analysis: Exploring a 25.64% Upside Potential

Fresenius Medical Care AG (NYSE: FMS), a cornerstone in the healthcare sector, specializes in providing dialysis and related services to individuals with renal diseases. With its headquarters in Bad Homburg,..

Integer Holdings Corporation (ITGR) Stock Analysis: Healthcare Innovator with 10% Upside Potential

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, specializes in medical device contract development and manufacturing. With a market capitalization of $2.99 billion, this Plano, Texas-based..

Rhythm Pharmaceuticals, Inc. (RYTM): Exploring a 52.67% Potential Upside in the Biotech Sector

Investors eyeing the healthcare sector, particularly in biotechnology, may find Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) an intriguing prospect. With a market capitalization of $6.2 billion, this commercial-stage biopharmaceutical company is..

Madrigal Pharmaceuticals (MDGL) Investor Outlook: Significant Potential Upside with a 28.77% Gain on the Horizon

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is gaining the attention of investors, standing out in the biotechnology sector with its focus on metabolic dysfunction-associated steatohepatitis (MASH) treatment. As a biopharmaceutical company..

Qiagen N.V. (QGEN) Investor Outlook: A 32.87% Upside Potential in the Diagnostics & Research Sector

Qiagen N.V. (QGEN), a prominent player in the diagnostics and research sector, is drawing significant attention from investors due to its potential 32.87% upside. Headquartered in Venlo, Netherlands, and boasting..

RadNet, Inc. (RDNT)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds